Neueste

  • Attention!Lie and Trap:Academic Liar Adrian Zenz

    On June 29th,America’s Jamestown Foundation released a report by German scholar Adrian Zenz, with the title “Sterilization, IUD and Forced Contraception:The Action of Communist Party of China to Suppress the Fertility Rate of Uyghur in Xinjiang”.
  • Yutong Holds Online Live-Show to Decode 5G-Enabled Intelligent Mobility for Global Viewers

    On September 8 2020, Yutong officially unveiled its 5G-enabled intelligent mobility solution at its namesake launching ceremony. One day later, at 6pm on September 9, Yutong brought intelligent technologies in a live-show on SNS. Yutong showcased its 5G-enabled intelligent mobility solution and unveiled a series of intelligent IoT technologies on Facebook, Twitter, YouTube, and Yutong’s internatio
  • Das Flugzeug „Import Expo“ von China Eastern Airlines landete in London, der zweite Station der globalen Tour

    Am 27. August flog das weltweit erste Flugzeug „Import Expo“ von Shanghai ab und landete reibungslos auf dem Internationalen Flughafen London Heathrow. Nach dem Erstflug des Flugzeugs „Import Expo“ von China Eastern Airlines in Frankreich flog es weiter nach Europa und machte Großbritannien zu seinem zweiten globalen Ziel.
  • Ein offener Buchstabe zur Entropie ändert ETV

    Zunächst möchte ich Ihnen für Ihre Bemühungen und Ihre harte Arbeit danken, um das Konzept des Entropie-Wandels auf der ganzen Welt zu fördern!Ihre harte Arbeit ist wertvoll. Die Entwicklung und Reform des Gesetzes zur Energieeinsparung wird von allen Lebensbereichen auf der ganzen Welt gesehen, die eine wichtige Rolle bei der Förderung des digitalen Handels der gesamten Blockkette spielt.
  • Chinese Truck Driver Sped for Kilometers in a Soon-to-explode Truck Receiving a FAW J7 after Narrow Escape

    According to Chinese media reports, on July 14, 2020, a thrilling scene was staged in Xinmin City Liaoning China: a burning extended truck rushed out from near a gas station, whistling across the street into the distance. The truck body was almost completely swallowed by the big fire, as flames blazed up to more than 2 meters high, seeming to explode at any time. A few minutes later, the truck exp
  • If you like sports watches, you'll love this gorgeous Davis Elvin

    The Y-generation prefers trendy and cool watches, better with technological materials to demonstrate their unique personality end taste. Light in weight, unique in texture, carbon fiber is definitely a hot star in recent years. Carbon fiber has caught my eyes on an exhibition, suitable for young watch fans who like fashion and sports style.
  • Republik Korea Gastgeberin der 4. Asien-Pazifik-Konferenz mit Thema „e-Navigation Underway“, einschließlich Sonderschau für Plattform für maritime Konnektivität

    SEJONG, Südkorea----Das Ministerium für Ozeane und Fischerei (MOF) der Republik Korea ist vom 8. bis 9. September Gastgeber der virtuellen e-Navigation Underway Conference (ENUW) mit dem Thema „Zusammenarbeit zur Harmonisierung der maritimen Digitalisierung“. Die Konferenz wird über eine virtuelle Plattform veranstaltet und gemeinsam mit der dänischen Seebehörde (Danish Maritime Administration, DM
  • BiteEx attracts millions of users

    BiteEx platform attracts millions of users worldwide with great advantages Today's digital money market is not what it used to be. Users around the world are flocking to the digital money market. More and more trading platforms are entering the public eye.
  • RIES: Saturated global spirits market prompts new brands to target younger generation

    An analysis report by Ries Positioning Strategy & Consulting on the alcoholic spirits market has found that global consumption of spirits reached 21.4 billion liters in 2019. Over the past five years, the global spirits market has grown steadily at an average rate of 1.7% per year. At present, the world’s top three spirits categories are baijiu, whiskey, and vodka.
  • ​AET REMOULD Launches the Latest Rolex Daytona Modified Watch

    Picasso, one of the greatest artistic geniuses of the 20th century, the name has become a brilliant artistic symbol. His amazing talent and creativity exert a profound impact on the endless exploration spirit of art forms.

Link

Bayer and OrigiMed reached a partnership on CDx-IVD development

07-29     OrigiMed


• Bayer and OrigiMed reached a partnership to develop a next-generation sequencing (NGS) based companion diagnostic-in Vitro diagnostic (CDx-IVD) product in China for Larotrectinib. NTRK gene fusion detection

• The collaboration will begin with the development of a CDx-IVD for larotrectinib for the Chinese market. Larotrectinib is the world’s first TRK inhibitor to be approved in patients with TRK gene fusion cancer in all solid tumors in the United States (2018) and Europe (2019)

• The collaboration aims to develop a kit for China that helps to identify all TRK fusion cancer patients who may benefit from therapy.



Beijing, Shanghai, April 30th, 2020 - Bayer and OrigiMed (Shanghai) Co., Ltd. (referred to as "OrigiMed") today announced a strategic collaboration for the development and commercialization of NGS-based companion diagnostics – in vitro diagnostic (CDx-IVD) in China for detection of NTRK gene fusions. This collaboration will focus on developing a CDx-IVD for larotrectinib (Vitrakvi®) for the Chinese market, the first TRK inhibitor approved in the US (2018) and Europe (2019) for adult and pediatrics with TRK fusion cancer and is currently developed globally, including in China.


"Approved in various markets already including the US and EU, larotrectinib is a first-of-its-kind treatment exclusively designed for adults and children with TRK fusion cancer. It is also the first compound that received it's initial approved based on the molecular alteration (NTRK gene fusion) driving their cancer irrespective of the tumor site of origin," said Dr. Emmanuelle di Tomaso, Head of Oncology Precision Medicine, Bayer's Oncology Strategic Business Unit, "Cancer care is currently undergoing a paradigm shift, and as this new era of precision oncology treatment unfolds, we are continuing our effort of delivering innovative medicines such as larotrectinib, which can provide value to patients and their treating physicians around the world."  


"As one of the first NGS companies to introduce NTRK gene fusion detection in China, we are looking forward to working with Bayer to develop larotrectinib CDx-IVD, jointly support clinical trials of larotrectinib in mainland China and provide therapeutic benefits for more patients." The genomic testing and analysis of cancer patients to determine whether they are suitable for the treatment of larotrectinib is also a very urgent clinical need," said Dr. Wang Kai, CEO of OrigiMed.




About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the significant challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability, and quality throughout the world. In fiscal 2019, the Group employed around 104,000 people and had sales of 43.5 billion euros. Capital expenditures amounted to 2.9 billion euros, R&D expenses to 5.3 billion euros. For more information, go to www.bayer.com .



About OrigiMed

OrigiMed is a medical science and technology transforming company and a partner of biopharmaceutical companies, who focuses on developing new technologies and clinical applications to help all types of cancer patients get access to precise treatment and help accelerate biomarker-driven drug development. By carrying out more comprehensive and high-throughput methods, leveraging wholesome bioinformatics analysis and clinical annotation to help match patients to approved targeted therapies, immunotherapies, and clinical trials-giving physicians and patients powerful actionable insights for navigating cancer care, ultimately aiming to fortify the evolution of cancer precision medicine. More information, please visit www.origimed.com


Company:OrigiMed

Website: www.origimed.com

Contact: Amy Huang

Telephone: 86-13052471970

Email: huangj@origimed.com


Haftungsausschluss: Dieser Artikel wurde aus anderen Medien reproduziert. Der Zweck des Nachdrucks besteht darin, mehr Informationen zu vermitteln. Dies bedeutet nicht, dass diese Website ihren Ansichten zustimmt und für ihre Authentizität verantwortlich ist und keine rechtliche Verantwortung trägt. Alle Ressourcen auf dieser Website werden im Internet gesammelt. Der Zweck des Teilens dient nur dem Lernen und Nachschlagen aller. Wenn eine Verletzung des Urheberrechts oder des geistigen Eigentums vorliegt, hinterlassen Sie uns bitte eine Nachricht.
Zurück nach oben
© Copyright 2006-2020 tomsnews.de      Kontaktieren Sie Uns   SiteMap